Corrigendum: Adenosine A2A Receptor Suppressed Astrocyte-Mediated Inflammation through the Inhibition of STAT3/YKL-40 Axis in Mice with Chronic Cerebral Hypoperfusion-Induced White Matter Lesions

Corrigendum: Adenosine A2A Receptor Suppressed Astrocyte-Mediated Inflammation through the Inhibition of STAT3/YKL-40 Axis in Mice with Chronic Cerebral Hypoperfusion-Induced White Matter Lesions

Bibliographic Details
Main Authors:	Jichao Yuan, Lin Chen, Jie Wang, Simin Xia, Jialu Huang, Linke Zhou, Chengjian Feng, Xiaofei Hu, Zhenhua Zhou, Hong Ran
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Immunology
Subjects:	adenosine A2A receptor (ADORA2A) astrocyte inflammation YKL-40 white matter lesions
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.883172/full

Similar Items

Dietary adenosine supplementation improves placental angiogenesis in IUGR piglets by up-regulating adenosine A2a receptor
by: Zifang Wu, et al.
Published: (2023-06-01)

The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
by: Wei Ruan, et al.
Published: (2022-08-01)

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
by: Marta Querol-Vilaseca, et al.
Published: (2017-06-01)

Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice
by: Xiaoyan Zeng, et al.
Published: (2023-12-01)

A genetic variation in the adenosine A2A receptor gene contributes to variability in oscillatory alpha power in wake and sleep EEG and A1 adenosine receptor availability in the human brain
by: Naemi L. Tichelman, et al.
Published: (2023-10-01)

Alternative adenosine Receptor activation: The netrin-Adora2b link
by: Xiaoyi Yuan, et al.
Published: (2022-07-01)

Reduced neurobehavioral impairment from sleep deprivation in older adults: Contribution of adenosinergic mechanisms
by: Hans-Peter eLandolt, et al.
Published: (2012-04-01)

Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b
by: Izaskun Villar-Menéndez, et al.
Published: (2014-09-01)

A Comparative Study Of Lamps And Ykl-40 Tissue Expression In Glial Tumors
by: Kazakova Maria Hr., et al.
Published: (2014-09-01)

YKL-40 IN SERA OF BREAST TUMOR PATIENTS
by: Maria Kazakova, et al.
Published: (2010-07-01)

YKL-40 in high-grade glioma: Prognostic value of protein versus mRNA expression
by: Yu-Hang Zhao, et al.
Published: (2018-01-01)

YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
by: Ioannis Mavroudis, et al.
Published: (2021-12-01)

YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis?
by: Kazakova Maria H., et al.
Published: (2017-03-01)

Gestasyonel Diyabetes Mellituslu Gebelerde Serum YKL-40 Düzeyi
by: Mahmut Oncul, et al.
Published: (2022-03-01)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
by: Maria Gevezova, et al.
Published: (2023-11-01)

A novel biomarker in acute cholecystitis: YKL-40
by: Eray Çeliktürk, et al.
Published: (2023-04-01)

SERUM YKL-40 LEVELS IN CHRONIC HEART FAILURE.
by: Maria Kazakova, et al.
Published: (2014-06-01)

Overexpression of chitinase like protein YKL-40 in leukemia patients
by: Anil K. Hurmale, et al.
Published: (2013-01-01)

YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children
by: Xingge Yang, et al.
Published: (2018-12-01)

Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
by: Mohammad Reza Jafari-Nakhjavani, et al.
Published: (2019-01-01)

Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
by: Kim Hyun, et al.
Published: (2012-07-01)

Staphylococcus aureus suppresses the pentose phosphate pathway in human neutrophils via the adenosine receptor A2aR to enhance intracellular survival
by: Emilio G. Vozza, et al.
Published: (2024-01-01)

Insulin treatment corrects hepcidin but not YKL-40 levels in persons with type 2 diabetes mellitus matched by body mass index, waist-to-height ratio, C-reactive protein and Creatinine
by: Driton Vela, et al.
Published: (2017-08-01)

YKL-40 – A NEW DIAGNOSTIC BIOMARCER FOR BENIGN BREAST DISEASES AND BREAST CANCER
by: Vanya Uzunova, et al.
Published: (2010-07-01)

Activation of astrocytes in hippocampus decreases fear memory through adenosine A1 receptors
by: Yulan Li, et al.
Published: (2020-09-01)

Strong YKL-40 expression in the invasive tumor front of colorectal cancer–A pilot study
by: Maria Kazakova, et al.
Published: (2024-03-01)

YKL-40 Aggravates Early-Stage Atherosclerosis by Inhibiting Macrophage Apoptosis in an Aven-dependent Way
by: Wei Huan, et al.
Published: (2021-12-01)

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
by: Tong X, et al.
Published: (2018-01-01)

Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer
by: Il Hwan Oh, et al.
Published: (2021-08-01)

Conserved YKL-40 changes in mice and humans after postoperative delirium
by: Jennifer David-Bercholz, et al.
Published: (2022-12-01)

Serum YKL-40 is associated with the severity of coronary artery disease and hypertension
by: Yu Xing, et al.
Published: (2020-11-01)

Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation
by: Mitchell E. Granade, et al.
Published: (2022-09-01)

YKL-40 Gene Expression and Plasma Levels of CD30 are not Affected by Isoflurane or Propofol: Pilot Study
by: Shirin Lak, et al.
Published: (2016-10-01)

Extracellular adenosine-mediated modulation of regulatory T cells
by: Akio eOhta, et al.
Published: (2014-07-01)

Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer
by: Mariangela De Robertis, et al.
Published: (2022-11-01)

Is YKL-40 (CHI3-L1) a new possible biomarker prognosticator in high grade glioma?
by: A. Oslobanu, et al.
Published: (2015-09-01)

Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission
by: Guillaume Dorcet, et al.
Published: (2023-01-01)

Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
by: Camilla Bjørnbak Holst, et al.
Published: (2020-04-01)

YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition
by: Hailong Hao, et al.
Published: (2021-01-01)